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ARTICLE
Increased autophagy in EphrinB2-deﬁcient
osteocytes is associated with elevated secondary
mineralization and brittle bone
Christina Vrahnas 1,2,12, Martha Blank1,2, Toby A. Dite 2,3,12, Liliana Tatarczuch 4, Niloufar Ansari 1,2,
Blessing Crimeen-Irwin1, Huynh Nguyen5, Mark R. Forwood 5, Yifang Hu6, Mika Ikegame 7,
Keith R. Bambery 8, Cyril Petibois 9, Eleanor J. Mackie 4, Mark J. Tobin 8, Gordon K. Smyth 6,10,
Jonathan S. Oakhill 2,3,11, T. John Martin 1,2 & Natalie A. Sims 1,2
Mineralized bone forms when collagen-containing osteoid accrues mineral crystals. This is
initiated rapidly (primary mineralization), and continues slowly (secondary mineralization)
until bone is remodeled. The interconnected osteocyte network within the bone matrix dif-
ferentiates from bone-forming osteoblasts; although osteoblast differentiation requires
EphrinB2, osteocytes retain its expression. Here we report brittle bones in mice with
osteocyte-targeted EphrinB2 deletion. This is not caused by low bone mass, but by defective
bone material. While osteoid mineralization is initiated at normal rate, mineral accrual is
accelerated, indicating that EphrinB2 in osteocytes limits mineral accumulation. No known
regulators of mineralization are modiﬁed in the brittle cortical bone but a cluster of
autophagy-associated genes are dysregulated. EphrinB2-deﬁcient osteocytes displayed more
autophagosomes in vivo and in vitro, and EphrinB2-Fc treatment suppresses autophagy in a
RhoA-ROCK dependent manner. We conclude that secondary mineralization involves
EphrinB2-RhoA-limited autophagy in osteocytes, and disruption leads to a bone fragility
independent of bone mass.
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The skeleton is unique because its organic structure is har-dened by integration of mineral, allowing it to providesupport for locomotion and protection for internal organs.
This mineralized bone forms when collagen-containing osteoid,
deposited by osteoblasts, accrues hydroxyapatite crystals. The
process has two phases: a rapid initiation (primary mineraliza-
tion), followed by slower mineral accrual (secondary miner-
alization) that continues until it reaches a maximal level, or the
bone is renewed by remodeling1. During bone formation, osteo-
blasts become incorporated in the non-mineralized osteoid and
differentiate into osteocytes to form a highly connected network
of specialized cells residing within the mineralized matrix2. In
response to stimuli such as mechanical load, hormones, and
cytokines, osteocytes release proteins that both stimulate3 and
inhibit4 bone-forming osteoblasts. Both osteoblasts and osteo-
cytes express proteins that initiate osteoid matrix mineralization5,
but it is not known how continuing mineral deposition is
controlled.
Two related agents that stimulate bone formation are the
agonists of the parathyroid hormone (PTH) receptor (PTH1R):
PTH and PTH-related protein (PTHrP). Locally derived PTHrP,
from osteoblasts and osteocytes, stimulates bone formation in a
paracrine manner6. This PTH1R-mediated action is exploited by
the pharmacological agents teriparatide (PTH) and abaloparatide
(modiﬁed N-terminal PTHrP), two agents currently available that
increase bone mass in patients with fragility fractures7,8. The
contact-dependent signaling molecule EphrinB2 is substantially
increased in osteoblasts by both PTH and PTHrP treatment
in vitro and in vivo9. We have previously shown that EphrinB2
(gene name: Efnb2) interacts with its receptor, EphB4, to provide
a checkpoint through which osteoblasts must pass to reach full
maturity10,11. Furthermore, in adult bone, osteoblast-speciﬁc
EphrinB2 deletion compromised bone strength by impairing
osteoblast differentiation and delaying initiation of bone miner-
alization, ultimately leading to a mild osteomalacia (high osteoid
content)11. This indicated that osteoid mineralization is initiated
by mature osteoblasts beyond the EphrinB2:EphB4 differentiation
checkpoint.
We were intrigued by the high level of EphrinB2 expression in
fully embedded osteocytes9, beyond the differentiation check-
point. Given the extensive connections between osteocytes2 and
the contact-dependent nature of EphrinB2:EphB4 signaling, we
hypothesized that EphrinB2 might regulate osteocyte function in
the bone matrix. We undertook the present work to determine
the requirement for EphrinB2 expression in osteocytes. We found
that EphrinB2 in osteocytes does not regulate initiation of bone
mineralization, but limits secondary mineral accrual and retains
bone matrix ﬂexibility. We also showed that osteocytes lacking
EphrinB2 have modiﬁed genes associated with autophagy and
increased autophagosomes, and that EphrinB2 suppresses
autophagy in a RhoA-ROCK-dependent manner; this provides
evidence that autophagic processes in osteocytes may directly
control mineralization.
Results
PTH and endogenous PTHrP increase EphrinB2 in osteocytes.
Upregulation of Efnb2 messenger RNA (mRNA) in osteocytes by
PTH and PTHrP stimulation was conﬁrmed in the Ocy454
osteocyte cell line (Fig. 1a); PTH(1–34) and PTHrP(1–141) both
signiﬁcantly increased Efnb2 mRNA levels. Short hairpin RNA
(shRNA) knockdown of PTHrP (Pthlh) in Ocy454 cells resulted
in signiﬁcantly lower Efnb2 mRNA levels at all timepoints,
compared to vector control (Fig. 1b). This indicates that endo-
genous PTHrP expression by osteocytes is required for normal
Efnb2 expression in osteocytes.
EphrinB2 deletion in osteocytes causes brittle bones. To con-
ﬁrm speciﬁc Efnb2 deletion, green ﬂuorescent protein (GFP)-
tagged osteocytes were ﬂuorescence-activated cell sorting (FACS)
puriﬁed from Dmp1Cre.DMP1tg-GFP.Efnb2f/f mice. PCR with
primers targeted to the Efnb2 exon 1–2 boundary conﬁrmed
effective Efnb2 targeting in osteocytes from Dmp1Cre.Efnb2f/f
mice, while retaining Efnb2 in non-osteocytic cells (Fig. 1c). Efnb2
was present in GFP-tagged osteocytes from control mice.
Three-point bending tests demonstrated a whole bone strength
defect in adult female Dmp1Cre.Efnb2f/f femora compared to
Dmp1Cre controls (Fig. 1d–i, Supplementary Table 1), but not in
males (Supplementary Table 2). For this reason, all further
analysis is focused on the female bones. A signiﬁcantly higher
percentage of bones from female Dmp1Cre.Efnb2f/f mice fractured
at lower deformation than controls (Fig. 1e). Average
load–deformation curves showed this also (Fig. 1d), and femora
from Dmp1Cre.Efnb2f/f mice could withstand less force before
yielding (yield force, Supplementary Table 1) and before breaking
(ultimate force, Fig. 1f), and deformed less at the maximum force
that they could withstand (ultimate deformation, Fig. 1h),
compared to controls. The low ultimate deformation was largely
explained by a deﬁcit in deformation from the yield point
onwards (post-yield deformation, Fig. 1h, Supplementary
Table 1). Energy absorbed to failure was also signiﬁcantly lower
in Dmp1Cre.Efnb2f/f femora compared to controls (Fig. 1i).
Stiffness (slope of the load–deformation curve before the yield
point) was not signiﬁcantly modiﬁed (Supplementary Table 1).
This indicates a lower yield point in Dmp1Cre.Efnb2f/f femora,
and once they began to yield, they withstood less force and
deformed less than controls.
The impaired Dmp1Cre.Efnb2f/f femoral strength was not
associated with any signiﬁcant difference in moment of inertia
(Fig. 2a) or cortical bone dimensions (periosteal perimeter and
marrow area, Supplementary Table 1). Indeed, when data were
corrected for cortical dimensions, impaired strength was still
observed. This conﬁrmed that the defect in strength was not due
to modiﬁed bone shape. Femora from Dmp1Cre.Efnb2f/f mice
showed impaired material strength compared to controls (Fig. 2b),
including lower yield stress and strain (Supplementary Table 1),
lower ultimate stress (Fig. 2c), lower ultimate strain (Fig. 2d), and
lower toughness (Fig. 2e). Elastic modulus was not signiﬁcantly
altered (Supplementary Table 1), consistent with the normal
stiffness. Reference point indentation (RPI) also indicated a
change in material strength independent of geometry, with a
signiﬁcantly greater indentation distance increase (the increase in
the test probe’s indentation distance in the last cycle relative to
the ﬁrst cycle) in Dmp1Cre.Efnb2f/f bones compared to controls
(Fig. 2f). No other parameters measured by RPI were altered
(Supplementary Table 3). Dmp1Cre.Efnb2f/f femoral fragility is
therefore due to a change in the bone material itself, likely a
defect in bone material composition.
Normal bone formation rate in Dmp1Cre.Efnb2f/f bones. In
contrast to OsxCre.Efnb2f/f mice (with EphrinB2 deleted in
osteoblasts), which exhibited reduced mineral appositional rate at
the periosteum11, Dmp1Cre.Efnb2f/f mice exhibited no signiﬁcant
change in periosteal mineral appositional rate (Supplementary
Table 1) or periosteal mineralizing surface (Supplementary
Table 1). We also assessed trabecular bone structure, which was
normal (Supplementary Table 4), and detected no signiﬁcant
difference in trabecular bone formation rate, mineral appositional
rate, or mineralizing surface (Supplementary Table 5). There were
also no differences detected in osteoid thickness, osteoid surface,
osteoblast surface, or osteoclast surface in Dmp1Cre.Efnb2f/f
bones compared to controls (Supplementary Table 5). Osteoblast
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differentiation, osteoblast-mediated osteoid deposition, and the
initiation of bone mineralization therefore occur at a normal rate
in Dmp1Cre.Efnb2f/f bones.
Backscattered electron microscopy detected no change in
osteocyte lacunar size in Dmp1Cre.Efnb2f/f femoral midshafts;
however, osteocyte lacunar density was signiﬁcantly greater
compared to controls (Supplementary Table 6). This suggests
that osteocytes are incorporated more rapidly into the bone
matrix during osteoid deposition. No defect in the osteocyte
lacuno-canalicular network was detected by Ploton silver staining
(Supplementary Fig. 1).
Greater mineral deposition in Dmp1Cre.Efnb2f/f bone. Since
material strength was impaired and the (blinded) technician
cutting the sections for histomorphometry noted difﬁculty in
cutting many samples, we assessed bone material by multiple
methods. We detected no difference in the proportion of woven
to lamellar cortical bone by polarized light microscopy (Supple-
mentary Table 6) and no signiﬁcant alteration in cortical tissue
mineral density (Ct.TMD) measured by micro computed tomo-
graphy (Supplementary Table 1) in Dmp1Cre.Efnb2f/f femora
compared to controls. We then used synchrotron-based Fourier-
transform infrared microspectroscopy (sFTIRM) to measure bone
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Fig. 1 Parathyroid hormone (PTH) and PTH-related protein (PTHrP) stimulate Efnb2 in osteocytes and bone strength is impaired in mice lacking EphrinB2 in
osteocytes. a, b Efnb2 messenger RNA (mRNA) levels, relative to Hprt1, in Ocy454 cells differentiated for 14 days and treated with 10 nM hPTH(1–34) or
hPTHrP(1–141) for 6 h (a) and Ocy454 cells with stable short hairpin RNA (shRNA) knockdown of PTHrP (Pthlh) at 0, 7, and 14 days of differentiation (b).
Data are mean ± SEM, n= 6 replicates; representative of three independent experiments; *p < 0.05, **p < 0.01, ***p < 0.001 compared to control by
Student’s t test. c Efnb2 mRNA levels in green ﬂuorescent protein-positive (GFP+) osteocytes isolated from Dmp1Cre.DMP1-GFP-Tg.Efnb2w/w (w/w) and
Dmp1Cre.DMP1-GFP-Tg.Efnb2f/f (f/f) mice compared to GFP− cells. ND= not detected. Data mean ± SEM of two experiments, n= 6 mice/group; pooled.
d Average load–deformation curve from three-point bending tests (each dot represents the average for the noted sample group; error bars excluded to
highlight the shape of curves) of femora from 12-week-old female Dmp1Cre.Efnb2f/f (f/f) mice and Dmp1Cre controls (w/w). e Kaplan–Meier curve showing
percentage of unbroken femora with increasing deformation (p value from Mantel–Cox log-rank test). f–i Calculated indices of bone strength: ultimate
force (f), ultimate deformation (g), post-yield deformation (h), and energy absorbed to failure (i). Data are mean ± SEM, n= 10–12/group. *p < 0.05, **p <
0.01, ***p < 0.001 vs. w/w controls by Student’s t test
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composition at the medial tibial periosteum. Unlike the endo-
cortical surface, which is remodelled, the periosteal surface is a
site of modelling-based cortical expansion and undergoes con-
tinuous bone formation (bone growth)12. We have conﬁrmed this
in control mice for this study at the site used for sFTIRM analysis
at both 6 and 12 weeks of age (Supplementary Fig. 2). Mea-
surements taken at increasing depth thereby allow assessment of
bone matrix mineralization rate as it progresses13,14. Three
regions with increasing matrix maturity were measured (Fig. 3a).
Average spectra for each genotype, taken from the intermediate
region, indicated altered spectral geometry in Dmp1Cre.Efnb2f/f
bone compared to controls (Fig. 3b). Dmp1Cre.Efnb2f/f bone had
higher phosphate and carbonate peaks, indicating a greater
mineralization level. In addition, Dmp1Cre.Efnb2f/f bone showed
a lower amide I, but higher amide II peak, suggesting greater
collagen compaction in Dmp1Cre.Efnb2f/f bone.
When quantiﬁed, control bones showed the changes associated
with bone matrix maturation previously reported on murine
periosteum: with increasing depth from the bone edge, mineral:
matrix ratio increases, while amide I:II ratio decreases13
(Fig. 3c–e). Mineral accrual was accelerated in Dmp1Cre.Efnb2f/f
bone (Fig. 3c): in the two most immature regions, mineral:matrix
ratio was signiﬁcantly greater in Dmp1Cre.Efnb2f/f bone compared
to control (Fig. 3c) and amide I:II ratio was signiﬁcantly lower
(Fig. 3e). In addition, although carbonate:mineral ratio did not
increase signiﬁcantly with maturation in the control mice, the
carbonate:mineral ratio increased with increasing matrix maturity
in the Dmp1Cre.Efnb2f/f bone and reached a higher carbonate:
mineral ratio than controls in the two more mature regions
(Fig. 3d). The greater mineral:matrix ratio was not due to a lower
bone collagen content; hydroxyproline levels were signiﬁcantly
higher in whole bone samples from Dmp1Cre.Efnb2f/f bone
compared to control (Supplementary Table 6). Collagen cross-
linking did not change with bone maturity, but was signiﬁcantly
greater in the Dmp1Cre.Efnb2f/f intermediate region (Fig. 3f),
indicating that crosslinks mature in the same region in which
mineral and carbonate accumulate. Male Dmp1Cre.Efnb2f/f femora
showed no signiﬁcant modiﬁcation in mineral:matrix, carbonate:
mineral, or amide I:II ratio (Supplementary Fig. 3). The female
Dmp1Cre.Efnb2f/f brittle bone phenotype is therefore associated
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Fig. 2 Impaired strength in Dmp1Cre.Efnb2f/f mice is a material defect and is not caused by altered bone geometry. a Femoral moment of inertia. b–e Three-
point bending test data corrected for bone cross-sectional area, including average stress–strain curve (each dot represents the average load and
deformation for the noted sample group; error bars excluded to highlight the shape of curves) (b), ultimate stress (c), ultimate strain (d), and toughness
(e) of 12-week old female Dmp1Cre (w/w) and Dmp1Cre.Efnb2f/f (f/f) femora. f Indentation distance increase derived from reference point indentation. Data
are represented as mean ± SEM, n= 10–12/group. *p < 0.05, **p < 0.01 vs. w/w controls by Student’s t test
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with more rapid bone matrix maturation, including rapid mineral
accumulation and carbonate substitution, and more rapid collagen
compaction within the matrix.
Since the amide I:II ratio has not yet been validated in the bone
as an indicator of collagen compaction, we used polarized
Fourier-transform infrared imaging (pFTIRI) in the same region
to visualize and quantitate collagen ﬁber spatial variation (Fig. 4a,
b, d, e). We used 0° and 90° polarizing ﬁlters to preferentially
enhance the signal from molecular bonds oriented parallel and
perpendicular, respectively, to the bone tissue section surface15.
The pFTIRI 0° polarizing ﬁlter indicated higher amide I:II ratio in
both periosteal and endocortical regions compared to the central
cortical bone region (Fig. 4a, c). Dmp1Cre.Efnb2f/f bones showed
a greater amide I:II ratio in the endocortical region compared to
periosteal and central cortical bone (Fig. 4b, c). When quantiﬁed,
the pFTIRI 0° polarizing ﬁlter result conﬁrmed a signiﬁcantly
lower amide I:II ratio in the periosteal region in Dmp1Cre.Efnb2f/f
bone compared to control, validating our sFTIRM observations
(Fig. 4c). The difference in amide I:II ratio between periosteal and
central cortical regions was no longer detected due to this
lowering in the periosteal region: both showed a signiﬁcantly
lower amide I:II ratio than the endocortical region (Fig. 4b, c).
There was no reduction in amide I:II ratio on the endocortical
surface; since this region is remodelled, the bone in this region
would contain both old and new bone, which may mask any
difference. When quantiﬁed under 90° polarization, in both
control and Dmp1Cre.Efnb2f/f mice, amide I:II ratio was lower at
central and endocortical regions due to greater amide II signal
(Fig. 4d–f); no difference was observed in ﬁbers aligned under this
ﬁlter between genotypes (Fig. 4f). This analysis validated the
sFTIRM observations, and conﬁrmed a signiﬁcantly lower amide
I:II ratio in the more periosteal Dmp1Cre.Efnb2f/f bone than
control.
Dysregulated autophagy genes in Dmp1Cre.Efnb2f/f bone. To
identify mechanisms by which EphrinB2 deﬁciency alters mineral
and matrix composition leading to fragile bones, RNA-
sequencing was performed on marrow-ﬂushed femora from 12-
week-old Dmp1Cre.Efnb2f/f and control mice. This revealed 782
up-regulated genes and 1024 down-regulated genes (false dis-
covery rate <0.05). Known osteocyte-speciﬁc and mineralization
genes were not differentially expressed between the
genotypes (e.g., Dmp1, Mepe, Sost, Phospho1, Enpp1, Enpp2,
Fgf23). Table 1 shows the top 30 differentially expressed genes;
none have previously been associated with osteocyte function,
bone mineralization, or EphrinB2 function. We noted that a third
of the top genes are associated with autophagic processes, spe-
ciﬁcally with mitophagy and ER-phagy. Six were up-regulated in
the EphrinB2-deﬁcient bone: Fam134b16, Fbxo3217, Lama218,
Bnip319, Trim6320, and Peg321. The other four were down-regu-
lated: Eps8l122, Klf123, Tspo224, and Unc5a25. Genes associated
with canonical degradative macroautophagy (Atg genes) were not
signiﬁcantly modiﬁed.
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High autophagy and mineral in Efnb2-deﬁcient osteocytes. To
identify whether EphrinB2 deﬁciency in osteocytes leads to
increased autophagy in an independent cell-speciﬁc model, we
generated Efnb2-deﬁcient Ocy454 osteocytes and assessed
autophagy levels. Stable Efnb2 knockdown was conﬁrmed in
mature Ocy454 cells at days 11 and 14 (Fig. 5a).
Autophagy was measured in these cells by two methods. First,
the autophagosome marker LC3 was detected by immunoﬂuor-
escence. Efnb2 knockdown cells (both shRNA 1 and shRNA 2)
demonstrated signiﬁcantly more LC3 punctae than vector control
cells (Fig. 5b, c), indicating more autophagosomes in these cells at
basal conditions. In control cells, as expected, LC3 punctae were
elevated with baﬁlomycin A1, used as an autophagosome
degradation inhibitor to detect autophagosome formation26
(Fig. 5b, c). In Efnb2 knockdown cells with baﬁlomycin A1
treatment, LC3 punctae were not increased further (Fig. 5b, c).
This may be because it was not possible to induce a further
increase in autophagosome formation; indeed, since Efnb2
knockdown cells exhibited large accumulated punctae, a further
increase would be technically difﬁcult to quantify. Although this
method detected more autophagosomes in the basal state in
Efnb2 knockdown cells, it cannot distinguish whether this reﬂects
more autophagosome formation or less autophagosome
degradation.
To assess this speciﬁcally, we then assessed LC3-I to -II
lipidation by Western blot of cells treated with an alternative
lysosomal inhibitor, chloroquine. Chloroquine treatment signiﬁ-
cantly elevated LC3-II:I ratio in both vector and Efnb2 knock-
down cells (Fig. 5d, Supplementary Fig. 4). This effect was
ampliﬁed in Efnb2 knockdown cells. EphrinB2-deﬁcient osteo-
cytes therefore form more autophagosomes than vector control
cells (Fig. 5d).
To determine whether the increased autophagy is associated
with increased mineralization, Efnb2 knockdown Ocy454 cells
were grown for 2 weeks under mineralizing conditions. Cells
stably transfected with shRNA 2 did not survive mineralizing
conditions, but the cells expressing shRNA 1, like control cells,
remained conﬂuent under mineralizing conditions, and showed
greater mineralization than vector control cells (Fig. 5e, f). This
provides independent evidence that EphrinB2-deﬁcient osteo-
cytes have both a higher basal autophagy level and greater
mineralizing capacity than wild-type osteocytes.
To provide proof-of-principle evidence that increasing autop-
hagy can augment secondary mineralization by osteocytes, we
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tested the effect of the autophagy inducer rapamycin on
mineralizing Ocy454 cells. Indeed, Ocy454 mineralization was
elevated by 24 h of rapamycin treatment (Fig. 5g). This provides
direct evidence that stimulation of autophagy in osteocytes
increases mineralization.
More autophagosomes in Dmp1Cre.Efnb2f/f osteocytes. We
used transmission electron microscopy to assess bone-embedded
osteocytes in situ from adult Dmp1Cre.Efnb2f/f mice (Fig. 6).
Dmp1Cre.Efnb2f/f osteocytes were grossly abnormal; their cell
bodies were contracted, leaving a large open space within each
lacuna (Fig. 6a-c). This was even seen by light microscopy in
semi-thin sections, and when quantiﬁed throughout the cortical
bone, there were signiﬁcantly more osteocyte lacunae with small
or absent osteocyte bodies (mean ± SEM Dmp1Cre: 32.6 ± 3.2,
Dmp1Cre.Efnb2f/f: 49.6 ± 3.4; p= 0.044, by unpaired t test, n= 4
mice; data from 104 to 127 lacunae counted per sample at eight
sites, including both periosteal and endocortical regions).
Although cell bodies were small the Dmp1Cre.Efnb2f/f
osteocytes were clearly viable and active (Fig. 6b, c), and exhibited
extensive cell membrane rufﬂing, with abundant extrusions and
matrix vesicles budding from the cell surface; the latter is
consistent with EphrinB2-deﬁcient osteocytes actively promoting
mineralization in the surrounding matrix. Nuclei also had a
higher proportion of condensed chromatin. Although the cell
bodies within lacunae showed a striking shape change, dendritic
processes appeared normally throughout the bone matrix inside
the canaliculi (Fig. 6b, c), and a normal canalicular pattern was
observed by silver staining (Supplementary Fig. 1). Within the
cytoplasm, consistent with elevated LC3 detection in vitro,
Dmp1Cre.Efnb2f/f osteocytes exhibited abundant autophagosomes
at various stages, more than observed in control samples
(Fig. 7e–i). This included (1) condensations of degraded
endoplasmic reticulum (ER), (2) partially formed autophago-
somes (phagophores) actively encapsulating degraded ER cargo,
(3) fully formed autophagosomes surrounded by a double
membrane, including a single electron-dense region, and (4)
lysosomes (Fig. 6i); this provides evidence that the type of
autophagy promoted in EphrinB2-deﬁcient osteocytes is ER-
phagy. Sometimes, fully formed autophagosomes were observed
within the matrix vesicles (Fig. 6h). These degraded ER and
autophagosomes were not observed in control cells (Fig. 6a, d);
the most similar structure seen in wild-type cells was an
occasional rounded mitochondrion with clearly visible cristae
and lacking the electron-dense region; usually the mitochondria
were not spherical. This indicates high levels of both ER-phagy
and matrix vesicle release in Dmp1Cre.Efnb2f/f osteocytes in situ.
EphrinB2 increases osteocyte autophagosomes via RhoA-
ROCK. Since EphrinB2 has been reported to signal, at least in
part, through RhoA GTPase/ROCK signalling27, we next deter-
mined whether RhoA inhibition could mimic the effects of
EphrinB2 deletion on mineralization. To test this, we used Kusa
4b10 cells, which differentiate into osteocytes3, but mineralize at a
lower level than Ocy454 cells. In these cells, mineralization was
signiﬁcantly elevated by two RhoA inhibitors, H1152 and Y27632
(Fig. 7a–d). We next investigated whether treatment with clus-
tered EphrinB2-Fc would suppress autophagy, and whether this
would be amelioriated by blocking RhoA-ROCK signalling.
Neither H1152 nor EphrinB2-Fc, alone or in combination,
Table 1 Upregulation of autophagy-related genes by RNA-sequencing of Dmp1Cre.Efnb2f/f bone
Rank Gene name Gene ID Log 2 FC Avg Exprn T P value FDR
1 Ccdc92b 432582 −3.679 2.509 −17.73 4.23E-08 0.00063
2 BC049730 232972 −5.568 2.260 −11.20 1.92E-06 0.00948
3 Pira6 18729 1.788 2.245 10.52 3.19E-06 0.00948
4* Fam134b 66270 1.907 6.821 10.51 3.22E-06 0.00948
5* Fbxo32 67731 2.443 7.223 10.33 3.71E-06 0.00948
6 Vldlr 22359 1.224 6.325 10.30 3.80E-06 0.00948
7 Abca8a 217258 1.116 5.984 9.99 4.84E-06 0.00976
8 Cnksr1 194231 1.246 3.741 9.71 6.07E-06 0.00976
9 Sec14l2 67815 −1.066 5.350 −9.67 6.20E-06 0.00976
10 2610507I01Rik 72203 −4.421 3.956 −9.56 6.88E-06 0.00976
11* Eps8l1 67425 −4.100 2.602 −9.47 7.41E-06 0.00976
12* Lama2 16773 1.475 6.078 9.37 8.05E-06 0.00976
13* Bnip3 12176 1.363 5.117 9.21 9.31E-06 0.00976
14 Slc7a2 11988 1.437 5.507 9.19 9.46E-06 0.00976
15 Pirb 18733 −1.242 6.794 −9.15 9.78E-06 0.00976
16* Trim63 433766 2.476 7.151 9.02 1.09E-05 0.01019
17 Cped1 214642 0.993 5.745 8.92 1.19E-05 0.01029
18 Fam110c 104943 −3.115 0.935 −8.87 1.25E-05 0.01029
19 Klf9 16601 0.816 6.472 8.77 1.37E-05 0.01029
20* Klf1 16596 −1.095 7.140 −8.70 1.45E-05 0.01029
21 Zim1 22776 1.597 1.624 8.55 1.66E-05 0.01029
22 Abcg4 192663 −0.884 5.372 −8.49 1.76E-05 0.01029
23 Tspo2 70026 −1.010 5.864 −8.46 1.80E-05 0.01029
24* Unc5a 107448 −1.321 3.183 −8.45 1.83E-05 0.01029
25* Peg3 18616 1.748 4.988 8.44 1.84E-05 0.01029
26 Abca6 76184 1.576 3.620 8.44 1.84E-05 0.01029
27 Slc15a2 57738 1.446 4.194 8.43 1.86E-05 0.01029
28 Sycp1 20957 −3.876 −0.345 −8.17 2.37E-05 0.01149
29 Unc5cl 76589 −1.527 2.332 −8.16 2.40E-05 0.01149
30 Myo15 17910 1.291 2.933 8.09 2.56E-05 0.01149
The top 30 differentially expressed genes in marrow-ﬂushed Dmp1Cre.Efnb2f/f femora from female 12-week-old mice compared to Dmp1Cre controls. Autophagy-associated genes associated are in
bold, with *
Log 2 FC log 2 fold change, Avg exprn average log 2 expression, FDR false discovery rate
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modiﬁed LC3 punctae number without baﬁlomycin (Fig. 7f).
Baﬁlomycin treatment led to accumulation of LC3 punctae, and
EphrinB2-Fc treatment signiﬁcantly suppressed this (Fig. 7f),
conﬁrming less autophagosome formation. This was not observed
when EphrinB2-Fc treatment was given with H1152, a RhoA-
ROCK pathway inhibitor (Fig. 7f), indicating that EphrinB2-
signalling inhibits autophagy through RhoA-ROCK signalling.
Discussion
This work demonstrates that bone ﬂexibility is maintained, and
mineral accrual limited, by EphrinB2 signaling in osteocytes. In
EphrinB2 deﬁciency, autophagy is increased, and although
osteoid mineralization is initiated (MAR) at a normal rate, as
soon as the process commences, secondary mineral deposition
and maturation is accelerated, resulting in a brittle bone pheno-
type (Fig. 8). The control mechanisms for primary and secondary
mineralization are therefore different, and osteocytes within the
bone matrix contribute to secondary mineralization. This has
major implications for understanding how osteocytes control
bone strength.
Bone strength is determined by bone mass, and by bone matrix
composition. Bone mass is determined by the balance in activity
between bone-forming osteoblasts and bone-resorbing osteo-
clasts. Bone compositional strength is determined both by col-
lagen content and orientation, and, within the collagen network,
by mineral crystal content and nature. Defects in bone compo-
sitional strength have been noted to result from defective collagen
deposition (as in osteogenesis imperfecta) or delayed miner-
alization initiation (as in osteomalacia or rickets). In this study,
we report a third possible cause of bone fragility: accelerated
mineralized bone matrix maturation (secondary mineralization).
In brittle Dmp1Cre.Efnb2f/f bones, mineral:matrix ratio in the ﬁrst
region of mineral deposition was higher than controls. Since there
was no difference in MAR (the rate at which osteoid mineraliza-
tion is initiated), mineralization must proceed more rapidly after
initiation: essentially, once mineralization starts, the mineral is
deposited into the matrix at higher levels than normal. The
normal gradual increase in mineral:matrix ratio, previously
described in murine, rabbit, rat, and human cortical
bone13,14,28,29, was accelerated in the absence of EphrinB2.
This was not the only modiﬁcation to mineral accumulation.
Bone mineral crystals are a modiﬁed hydroxyapatite comprising
calcium, phosphate, and hydroxyl ions, which can be replaced by
ﬂuoride, chloride, or carbonate. As bioapatite matures in the
bone, carbonate:mineral ratio increases due to carbonate sub-
stitution for phosphate or hydroxyl ions13,30. Dmp1Cre.Efnb2f/f
bones also showed a more rapid increase in carbonate incor-
poration within the bone matrix. Both mineral accrual and car-
bonate substitution within the mineral are accelerated in the
absence of EphrinB2.
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A third acceleration in bone matrix maturation was the
reduction in the amide I:II ratio in Dmp1Cre.Efnb2f/f bones.
Amide I:II ratio represents peptide bond vibrations within the
collagen molecule31. Amide I (C=O stretch) and amide II (C-N,
N-H bend) molecular vibrations exhibit dichroism perpendicular
and parallel to the collagen molecular triple helix axis, respec-
tively. We have previously reported a decline in amide I:II ratio as
mineral accumulates during normal bone maturation; this is
likely due to increased compaction (or steric hindrance) in the
perpendicular direction of the collagen molecule as mineral
accumulates13. The earlier amide I:II ratio lowering in Dmp1Cre.
Efnb2f/f bone indicates more rapid collagen compaction as matrix
mineral accumulates; essentially, the collagen is more com-
pressed. Since the reduction in amide I:II was detected under the
0°, but not the 90°, polarizing ﬁlter, this may be speciﬁc to those
collagen ﬁbers aligned along the length of the bone, rather than
those with radial orientation transverse to the bone. This suggests
that the altered organization of longitudinal collagen ﬁbers may
be a main contributor to the EphrinB2-deﬁcient phenotype, and
these ﬁbers may be more important for absorbing mechanical
forces along the tibial length.
Another indicator of accelerated bone matrix maturation is the
greater osteocyte lacunar density in Dmp1Cre.Efnb2f/f bone. As
osteoid is deposited, some osteoblasts are incorporated into the
bone matrix and differentiate into osteocytes. Since osteoid
deposition is not accelerated, and mineral appositional rate
(initiation of mineralization) is unchanged in Dmp1Cre.Efnb2f/f
bone, the increased osteocyte density may indicate more rapid
osteocyte incorporation into the bone matrix. Dmp1Cre targets
late osteoblasts at the stage where they become embedded within
the newly formed osteoid;32 the greater density of osteocytes
incorporated may promote mineral accumulation and carbonate
incorporation in Dmp1Cre.Efnb2f/f bones, but whether this is
secondary to the increased mineralization or is causative is not
known and would be difﬁcult to test.
Although this is the ﬁrst report of a low amide I:II ratio being
associated with bone fragility, the cause of the brittle phenotype is
likely to be the combination of low amide I:II, and high mineral:
matrix and carbonate:mineral. An association of high carbonate
with increased bone fragility is consistent with a higher carbonate:
mineral ratio in bone specimens from women with post-
menopausal osteoporosis33 and with greater fracture suscept-
ibility34. High mineral:matrix ratio has also been reported in
other brittle bone conditions, such as patients with atypical
femoral fracture35, and murine osteogenesis imperfecta models36.
In the latter case, it is accompanied by defects in collagen or
cartilage content and in osteoblast function, but the present
model exhibited no change in osteoblast function.
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The processes controlling mineral accumulation in the bone
are poorly deﬁned and our data suggest that autophagic processes
in the osteocyte contribute. Unbiased RNA-sequencing detected
no changes in mRNA for genes known to regulate mineralization.
Instead, it identiﬁed a number of dysregulated autophagy-
associated genes. This led us to further investigations showing
elevated autophagosome numbers both in the EphrinB2 knock-
down osteocyte cell line, and in Dmp1Cre.Efnb2f/f osteocytes.
Autophagy is a group of lysosome-based recycling and secre-
tory processes contributing to diverse cellular functions, such as
adaptation to starvation, quality control of intracellular processes,
protein secretion, and elimination of intracellular microbes37.
Autophagy can be broadly categorized into two classes, canonical
degradative macro-autophagy, which involves Atg proteins, and
micro-autophagy (including mitophagy and ER-phagy), which
can be Atg-independent. While exploration of autophagy in
osteocytes is in its infancy, previous work demonstrated that
autophagy increases during osteoblast differentiation38, and mice
with osteoblast lineage or osteocytic deletion of either Atg5 or
Atg7 have reduced autophagy and osteoblast numbers38–40.
In our Dmp1Cre.Efnb2f/f mice osteoblast numbers were not
altered, indicating that the autophagic processes modiﬁed in
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EphrinB2-deﬁcient osteocytes do not change their signals that
control osteoblast differentiation. Furthermore mRNA levels of
Atg family members were not changed in Dmp1Cre.Efnb2f/f
bones, suggesting that EphrinB2 deﬁciency does not modify
canonical degradative macro-autophagy. Indeed, the top genes
dysregulated in the EphrinB2-deﬁcient bones have been asso-
ciated speciﬁcally with a subset of autophagic processes, including
mitophagy (degradation of mitochondria) and ER-phagy (micro-
autophagic degradation of the ER), as follows: Fam134b16,
Fbxo3217, Lama218, Bnip319, Trim6320, Peg321, Eps8l122, Klf123,
Tspo224, and Unc5a25. The abundant autophagosomes containing
degraded ER in osteocytes of Dmp1Cre.Efnb2f/f mice is consistent
with up-regulated ER-phagy, an Atg-independent process41.
When we used rapamycin as a broad-acting stimulus of autop-
hagy, mineralization by osteocytes was increased, providing proof
of principle that stimulating autophagy can stimulate miner-
alization by osteocytes. Whether rapamycin treatment in vivo
would increase bone stiffness by stimulating mineralization is not
known, and effects on other cell types are likely to mask such
action. We recently tested rapamycin treatment in wild type mice
and in the α2(I)‐G610C model of osteogenesis imperfecta42.
Although rapamycin increased trabecular bone mass, such
treatment also reduced cortical bone growth, thereby reducing
bone strength42. An increase in mineralization of bone deposited
during the rapamycin treatment period may have also played a
part in weakening the bone structure. Whether ER-phagy is
directly involved in mineral release remains to be tested, and will
require the development of ER-phagy-speciﬁc modulators.
The process of mineral incorporation within the extracellular
matrix is not well understood, and remains highly controversial.
The process involves matrix vesicles, which are extracellular
membrane-enclosed vesicles released by budding from cells at the
site of mineralization43, as seen in the Dmp1Cre.Efnb2f/f osteo-
cytes. Matrix vesicles were originally reported to lack mineral, and
to accumulate poorly crystalline mineral only after their expulsion
from the cell and immobilization in the collagen matrix43. The
amorphous mineral formed is subsequently nucleated (to ordered
crystals) in a process driven by contact with collagen, and by
secreted nucleators44,45. In contrast, a recent in vitro study
reported calcium phosphate crystals within intracellular vesicles
of osteoblast-like cells, and suggested that these are released as
mineral-containing matrix vesicles46. Nollet et al.38 also suggested
that osteoblasts could use autophagosomes as vehicles for apatite
crystal secretion into the extracellular space via exocytosis (i.e.,
secretory autophagy), and observed minerals within autophago-
somes in cultured osteosarcoma cells38. Whether osteocyte-
derived matrix vesicles that mediate secondary mineralization are
distinct from those released by osteoblasts is not known, nor is it
known yet whether matrix vesicles from EphrinB2-deﬁcient
osteocytes differ from wild type in their mineral content or
interaction with the collagen matrix. This would require study of
cultured osteocytes within a mineralized collagen substrate, or
assessment of mineral content within autophagosomes in bone
samples. Methods for culturing osteocytes within a mineralized
collagen substrate are not yet developed, and due to the high
mineral content of adult murine bone, decalciﬁcation was
required for TEM imaging of the bone specimens we studied; this
question therefore remains unresolved.
EphrinB2 has been previously reported to activate RhoA-
ROCK signalling in melanoma cells27. Our data indicate that
EphrinB2 suppresses autophagy in osteocytes, at least in part,
through a RhoA-ROCK-dependent pathway. Since RhoA-ROCK
inhibition both prevented the effects of EphrinB2-Fc on autop-
hagy and stimulated mineralization, this is likely to be at least one
pathway through which EphrinB2 limits mineralization and
autophagy. Whether RhoA-ROCK inhibition in osteocytes would
stimulate mineralization in vivo is not known; investigating this
in future would require a targeted approach, since RhoA-ROCK
signalling stimulates osteoblast commitment47 and is required for
osteoblast survival48.
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Fig. 8Model of osteocytic EphrinB2 regulation of bone matrix composition. a In control bone (Dmp1Cre) both osteoblasts and osteocytes express EphrinB2.
Osteoblasts reside on the bone surface, and pass through a transition (dashed arrows) to become mature, matrix-embedded osteocytes. Osteoblasts
deposit collagen-containing osteoid (triple helical collagen ﬁbers, shown on the right). In region 1 of newly formed bone, mineral deposition is initiated.
Mineral crystals (black stars) and carbonate (orange circles) continue to accumulate, and collagen ﬁbers become more compact as the matrix matures in
regions 2 and 3. b Dmp1Cre.Efnb2f/f mice express EphrinB2 in osteoblasts, but not osteocytes. Dmp1Cre.Efnb2f/f osteocytes have increased autophagy (green
cells). Osteoid deposition occurs normally, and the initiation of mineralization commences at the same rate, leading to osteoid of the same thickness (red
double-headed arrow). As soon as mineralization starts, mineral is deposited in Dmp1Cre.Efnb2f/f bone at a greater level than control in regions 1, 2, and 3 to
reach a level with more mineral, more carbonate substitution, and more compact collagen ﬁbers than controls. Ultimately this leads to more brittle bone.
c Close-up of the cell membrane in osteocytes in control and Dmp1Cre.Efnb2f/f bone: we propose that, in control mice, EphrinB2 suppresses autophagic
processes and limits matrix vesicle release via RhoA-ROCK signalling. In Dmp1Cre.Efnb2f/f mice loss of this inhibition leads to a high level of matrix vesicle
release, elevated mineralization, and a brittle bone matrix
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A comparison of this mouse model with our earlier model
lacking EphrinB2 throughout the osteoblast lineage provides new
information about the speciﬁc stages of osteoblast/osteocyte dif-
ferentiation and their roles in bone mineralization. That model
(OsxCre.Efnb2f/f) did not exhibit brittle bone, but had more elastic
bones because primary mineralization initiation was delayed11.
This indicated that the stage of osteoblast differentiation at which
primary mineralization is initiated is beyond the EphrinB2:EphB4
osteoblast differentiation checkpoint. In Dmp1Cre.Efnb2f/f mice,
osteoblasts survive past the checkpoint at which anti-apoptotic
EphrinB2 action is required; this allowed us to deﬁne an action
for EphrinB2 later in osteoblast differentiation. Normal initiation
of mineralization in Dmp1Cre.Efnb2f/f bone indicates that the
stage of osteoblast differentiation controlling this process is not
only after the EphrinB2:EphB4 checkpoint but also before the
stage of Dmp1Cre expression. In contrast, after Dmp1Cre is
expressed, osteocytes do not control mineralization initiation, but
control the rate at which minerals accumulate (Fig. 8). Since
exogenous PTH and endogenous PTHrP promote EphrinB2
expression in both osteoblasts9 and osteocytes, they may
both promote initiation of osteoid mineralization and restrain
mineral accrual. While there is no evidence for altered mineral
accrual with PTH pharmacological administration13, the reduced
material strength of mice with osteocyte-speciﬁc PTHrP dele-
tion49 suggests that PTHrP may regulate physiological mineral
accrual through EphrinB2-dependent actions to suppress autop-
hagy in the osteocyte.
These ﬁndings have implications for other cell types and organ
systems. EphrinB2 in odontoblasts, which are closely related cells
to osteoblasts and osteocytes50, may control mineralization in
teeth. EphrinB2 in hypertrophic growth plate chondrocytes may
control cartilage mineralization during endochondral ossiﬁcation;
this may contribute to the cartilage accumulation in neonate
Osx1Cre.Efnb2f/f mice51. Pathological mineralization, such as that
in heterotopic ossiﬁcation after trauma52, and vascular or renal
calciﬁcation53 may also be limited by EphrinB2, since it is
expressed in muscle, blood vessels, and kidney.
Sex differences in bone structure, strength, and remodeling
exist in all mammalian species, including humans and mice54,55,
and it is common for genetically altered mice to exhibit sex-
speciﬁc phenotypes56–58. Both the strength defect and the highly
mineralized bone of Dmp1Cre.Efnb2f/f mice detected here was
only observed in female mice. Our earlier work using Osx1Cre to
initiate EphrinB2 deletion earlier in the osteoblast lineage also
resulted in a female-speciﬁc phenotype11. However, there is no
evidence for direct regulation of Efnb2 in Ocy454 cells by either
estradiol or testosterone. We suggest that changes in bone matrix
composition may play a more signiﬁcant role in determining
bone strength in female bones because they have higher mineral
content and more rapid bone remodeling than male bones58,59.
In conclusion, EphrinB2 is required to limit autophagosome
numbers in osteocytes, and to prevent formation of brittle bone.
Osteocytic EphrinB2 limits autophagy through RhoA, and this
may be responsible for limiting mineral accumulation and car-
bonate substitution within the bioapatite matrix and restraining
collagen ﬁber compaction (Fig. 8). The EphrinB2-deﬁcient mouse
model indicates that such a mechanism can regulate bone
strength independently of both bone size and osteoblast and
osteoclast activities, and implies that autophagic processes within
the osteocytes may modify bone quality by regulating mineral
secretion.
Methods
Cell culture. Ocy454 cells were cultured in α-modiﬁed Eagle’s medium
(α-MEM) supplemented with 10% fetal bovine serum (FBS) and 1%
penicillin–streptomycin–amphotericin B (PSA) and Glutamax60. Cells were
maintained in permissive conditions (33 °C) and differentiated to osteocytes at
37 °C60. Ocy454 cells were plated at 2.5 × 105 cells per well in six-well plates.
Cells were grown at the permissive temperature (33 °C) for 3 days prior to
transferring to 37 °C for differentiation. To study Efnb2 mRNA regulation by
PTH and PTHrP, Ocy454 cells at day 14 of differentiation were serum depleted
overnight in α-MEM supplemented with 1% FBS and 1% PSA and Glutamax.
Cells were then treated with human PTH(1–34) (Bachem) (10 nM) or human
PTHrP(1–141)61 (10 nM) for 6 h. After 6 h, cells were washed with phosphate-
buffered saline (PBS) and RNA samples were collected as described below.
Undifferentiated Ocy454 cells were infected with Pthlh knockdown virus6, selected
with puromycin (5 μg/mL), and then cultured at permissive temperature (33 °C)
before transfer to 37 °C for differentiation. Cells were assessed by quantitative real-
time PCR (qRT-PCR) at day 0, 7, and 146. Rapamycin (0.05 nM, Sigma) was
administered to Ocy454 cells for 24 h after 6 days of differentiation in mineralizing
media such that mineralization had commenced at the time of treatment. Dimethyl
sulfoxide at the same volume was used as a negative control. Cells were stained
with Alizarin Red (Sigma). Since folding of the cell layer occurred at the edge of the
wells and trapped Alizarin Red stain, mineralization was quantiﬁed using areal
thresholding in a circular region (avoiding the folded areas) with ImageJ; values are
expressed as the percentage of the area measured62.
Kusa 4b10 cells, a murine stromal cell line, capable of osteocyte
differentiation63, were differentiated in mineralizing media (α-MEM with 15%
heat-inactivated FBS, 50 μg/mL ascorbate, and 5mM β-glycerophosphate), and
then treated with H1152 or Y27362 (0.2 and 1 μM) with each media change until
days 12 or 15, at which point cells were ﬁxed and stained with Alizarin Red
(Sigma), which was solubilized and quantiﬁed against a standard curve9.
qRT-PCR analysis. RNA was extracted from cultured cells by RNA extraction kits
with On-Column DNase digestion (Qiagen, Limburg, The Netherlands) or TriSure
reagent (Bioline, London, UK). Extracted RNA was DNase treated with Ambion
TURBO DNA-free Kit (Life Technologies) and quantiﬁed on a NanoDrop ND1000
Spectrophotometer (Thermo Scientiﬁc, Wilmington, DE, USA). Complementary
DNA (cDNA) was synthesized from total RNA with AfﬁnityScript cDNA Synthesis
Kits (Agilent Technologies, Santa Clara, CA, USA). Gene expression for PTH- and
PTHrP-treated Ocy454 cells were quantiﬁed on a Stratagene Mx3000P QPCR
System (Agilent) with SYBR Select Master Mix (Applied Biosystems) with primers
speciﬁc to Efnb2: forward 5′-GTGCCAGACAAGAGCCATGAA-3′ and reverse 5′’-
GGTGCTAGAACCTGGATTTGG-3′9. Gene expression for Pthlh knockdown cells
was analyzed using the Multiplex SensiMix II Probe Kits (Bioline, London, UK)
with primers speciﬁc to Efnb210. Gene expression levels were normalized to
hypoxanthine phosphoribosyltransferase 1 (Hprt1) expression10. Relative expres-
sion was quantiﬁed using the comparative CT method (2−(Gene Ct –Normalizer Ct)).
Mice. Dmp1Cre mice (Tg(Dmp1Cre)1Jqfe) (using the DMP1 10-kb promoter
region) were obtained from Lynda Bonewald (University of Kansas, Kansas City,
KS, USA)32 and EphrinB2-ﬂoxed (Efnb2tm1And) mice were obtained from David J.
Anderson (Howard Hughes Medical Institute, California Institute of Technology,
Pasadena, CA, USA);64 all were backcrossed onto C57BL/6 background. Mice
hemizygous for Dmp1Cre were crossed with Efnb2f/f mice to generate Dmp1Cre.
Efnb2f/w breeders, which were used to generate Dmp1Cre.Efnb2f/f mice and
Dmp1Cre.Efnb2w/w (Dmp1Cre) littermates or cousins; the latter were used as
controls for all experiments. Bone samples were collected at 6 and 12 weeks of age.
Calcein (20 mg/kg) was administered by intraperitoneal injection 7 and 2 days
before, and mice were fasted for 12 h prior to collection of tibiae and femora from
male and female mice; sample numbers were chosen based on previous studies
using adult genetically altered mice with alterations in bone mass and strength56.
All animal procedures were conducted with approval from the St. Vincent’s Health
Melbourne Animal Ethics Committee. All animals were assigned numbers at the
time of birth, and all animal procedures were conducted without the knowledge of
the genotype of the mice (blinded). At tissue collection, all samples were allocated a
second non-identifying number and all further analyses were conducted in a
blinded fashion and in random order, but no formal randomization procedure
was used.
Conﬁrmation of Efnb2 mRNA targeting in osteocytes. To conﬁrm speciﬁc
targeting of Efnb2 mRNA in osteocytes, Dmp1Cre.Efnb2f/f mice were crossed with
(Tg(Dmp1-Topaz)1Ikal) mice obtained from Dr. Ivo Kalajzic, University of Con-
necticut Health Science Center65 to allow GFP labelling of osteocytes and their
puriﬁcation by FACS66. Osteocytes from 6-week-old Dmp1Cre.Dmp1-GFP-Tg.
Efnb2w/w and Dmp1Cre.Dmp1-GFP-Tg.Efnb2f/f mice were isolated from marrow-
ﬂushed long bones by seven sequential 15-min digestions in 2 mg/mL dispase
(Gibco, Grand Island, NY, USA) and 1 mg/mL collagenase type II (Worthington,
Lakewood, NJ, USA). Fractions 2–7 were collected, pooled, and resuspended in α-
MEM (Gibco, Grand Island, NY, USA) containing 10% FBS and centrifuged at
400 × g for 5 min. Pellets were resuspended in FACS buffer before cell sorting. Prior
to sorting, dead cells and debris were removed based on side scatter (SSC) area and
forward scatter (FSC) area, and doublets were excluded based both on SSC width
(W) vs. SSC height (H) and on FSC-W vs. FSC-H. Cells were sorted with excitation
488 nm and 530/30- or 530/40-emission ﬁlter for GFP on a BD FACS Inﬂux cell
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sorter (BD Biosciences, Scoresby, Australia). RNA was extracted using Isolate II
Micro RNA Kit (Bioline, London, UK). cDNA was prepared using a Superscript III
Kit (Thermo Fisher, Scoresby, Australia). Gene expression levels of Efnb2 were
measured using primers directed to the genetically targeted region11 normalized to
β2 microglobulin (B2m) and hydroxymethylbilane synthase (Hmbs) or to Hprt1
using primers listed in Supplementary Table 7.
Three-point bending and RPI. Structural and material strength were analyzed in
femora from male and female 12-week-old mice by three-point bending56. Load
was applied in the anterior–posterior direction of the femoral mid-shaft between
two supports that were 6.0 mm apart. Load–displacement curves were recorded at a
crosshead speed of 1.0 mm/s using an Instron 5564A dual column material testing
system, and Bluehill 2 software (Instron, Norwood, MA, USA). Ultimate force,
ultimate deformation, post-yield deformation, and energy absorbed to failure were
measured from the load–displacement curves. Cortical dimensions including
anteroposterior (AP) and mediolateral (ML) widths were measured at the cortical
mid-shaft by micro-computed tomography (microCT). Moment of inertia was
calculated based on AP, ML, and cortical thickness6. The material properties,
corrected for geometry, were calculated for each bone to obtain ultimate stress,
ultimate strain, and toughness56.
Local bone material properties were examined by RPI at the femoral mid-shaft
with a BP2 probe assembly apparatus (Biodent Hfc; Active Life Scientiﬁc Inc.,
Santa Barbara, CA, USA)56. A 2 N maximum indentation force was achieved by
manually applying a 300 g reference force to femora. Five measurements were
taken per sample using a 2 N, 10-cycle indentation protocol. Pre- and post-
experiment measurements were taken on a polymerized methyl methacrylate
(MMA) block to ensure that probe assembly was not affected during testing.
Indentation distance increase was measured as the indentation distance in the last
cycle relative to the ﬁrst cycle.
Hydroxyproline assay in hydrolyzed bone samples. Following mechanical
testing, all fragments of the broken femora were ﬂushed of marrow, hydrolyzed,
and used for hydroxyproline assay to measure the collagen content31. Femoral
samples were cut with scissors at the mid-diaphysis and the distal half of the femur
was ﬂushed of marrow. The bone was weighed before and after dehydration in a
37 °C incubator for 1 h. Each sample was hydrolyzed by incubation overnight at
120 °C in 1 mL of 5M HCl per 20mg of bone. Fifty microliters of each sample was
used, and six serial dilutions of the hydroxyproline standard (1 mg/mL) were used
to generate a standard curve. Fifty microliters of chloramine T (Sigma-Aldrich) was
added to each reaction and incubated at room temperature for 25 min. Five
hundred microliters of Ehrlich’s Reagent (dimethyl-amino-benzaldehyde (Sigma-
Aldrich), n-propanol (99%, Sigma-Aldrich), perchloric acid (70%, AnalAR)) was
added to each reaction and incubated at 65 °C for at least 10 min. One hundred
microliters of each reaction was pipetted into a 96-well plate and absorbance was
measured using a POLARstar plate reader at 550 nm and interpolated on the
standard curve67.
Histomorphometry. Tibiae and femora from 12-week-old female mice were ﬁxed
in 4% paraformaldehyde, and embedded in MMA. To image the osteocyte network,
contralateral tibiae were decalciﬁed in EDTA, embedded in parafﬁn, sectioned, and
stained with Ploton silver stain10. Histomorphometry was conducted on MMA-
embedded samples with periosteal parameters measured on the tibial medial mid-
shaft (1500 µm from the base of the growth plate)68 and trabecular parameters
were measured in the secondary spongiosa, commencing 370 µm below the growth
plate, in a 1110 µm2 region in the proximal tibia68 (Osteomeasure; Osteometrics,
Atlanta, GA, USA).
Backscatter electron microscopy. Polarized light microscopy and backscatter
electron microscopy (BSEM) were performed on 100-µm-thick transverse sections
from the methacrylate-embedded femoral mid-shaft cut with a water-cooled Iso-
met Saw (Buehler, Lake Bluff, IL, USA). Irregular ﬁber orientation was measured as
woven bone, and well-aligned ﬁber orientation was measured as lamellar bone
using the Osteomeasure system (Osteometrics, Decatur, GA, USA)56. Gray-level
images of mineralized cortical bone were acquired by BSEM to identify osteocyte
lacunae on both anterior and posterior sides of the femur at ×500 magniﬁcation
(~600 μm in length) using an FEI Quanta FEG 200 solid-state backscattered
scanning electron microscope. Imaging was performed at low vacuum using water
at a 9.8 mm working distance. Lacunae were quantiﬁed using MetaMorph
(v.7.8.3.0; Molecular Devices, Sunnyvale, CA, USA) by establishing an inclusive
threshold for dark objects to distinguish bone from background. Integrated mor-
phometry analysis (IMA) was applied with a 2.43–24.31 μm2 ﬁlter for lacunar area,
to exclude cracks and blood vessels. Thresholded bone area, total lacunar area,
osteocyte lacunar size, size of the largest 20% of osteocyte lacunae, and osteocyte
lacunar density were measured. The osteocyte lacuno-canalicular network was
examined by Ploton silver staining69 of parafﬁn-embedded tibiae.
Micro-computed tomography. MicroCT was performed on femora using the
SkyScan 1076 System (Bruker-microCT, Kontich, Belgium). Images were acquired
using the following settings: 9 µm voxel resolution, 0.5 mm aluminum ﬁlter, 50 kV
voltage, and 100 µA current, 2600 ms exposure time, rotation 0.5°, frame
averaging= 1. Images were reconstructed and analyzed using NRecon (version
1.6.9.8), Dataviewer (version 1.4.4), and CT Analyzer (version 1.11.8.0). The
femoral trabecular analysis region of interest (ROI) was determined by identifying
the distal end of the femur and calculating 10% of the total femur length towards
the mid-shaft, where an ROI of 15% of the total femur length was analyzed. Bone
structure was measured using adaptive thresholding (mean of min and max values)
in CT analyzer. Cortical analyses were performed in a region of 15% of the femoral
length commencing from 30% proximal to the distal end of the femur and
extending toward the femoral mid-shaft. The lower thresholds used for trabecular
and cortical analysis were equivalent to 0.20 and 0.642 g/mm3 calcium hydro-
xyapatite (CaHA), respectively. Ct.TMD was analyzed in the same cortical ROI, as
described above. TMD calibration was performed using two phantom rods with
concentrations of CaHA of 0.25 and 0.75 g/cm3, scanned under the same condi-
tions and settings as the samples.
Synchrotron FTIR microspectroscopy. sFTIRM was used to examine bone
composition at the cortical diaphysis in 3 μm longitudinal sections of MMA-
embedded tibiae. Sections were imaged using a Bruker Hyperion 2000 IR micro-
scope coupled to a V80v FTIR spectrometer located at the IR Microspectroscopy
beamline at the Australian Synchrotron13. Sections were placed on 22 mm dia-
meter × 0.5 mm polished barium ﬂuoride (BaF2) windows (Crystan Limited, UK).
The microscope video camera was used to image the cortical diaphysis (1.5 mm
from the base of the growth plate), at the same location used for histomorpho-
metric measurements of periosteal mineral apposition (Fig. 5a). This location is
ideal for assessing mineral apposition on a formation surface, without any prior
remodeling because mouse bone lacks intracortical Haversian systems. sFTIRM
mapping was performed with the synchrotron source, with a 15 × 15 μm aperture.
Spectra were collected from three regions progressing perpendicularly into the
cortex, with the ﬁrst positioned at the periosteal edge (Fig. 5a). Spectra were
collected in the mid-infrared (IR) region from 750 to 3850 cm−1 using a nar-
rowband mercury cadmium telluride detector, at 8 cm−1 spectral resolution and
128 co-added scans per pixel spectral resolution in transmission mode. A matching
background spectrum was collected through clear BaF2. For each sample, MMA
reference spectra were collected within the embedding material. All data acquisi-
tion was undertaken with Bruker OPUS version 6.5 and data analysis used OPUS
version 7.2.
After acquisition, raw spectra for each region and sample were baseline
corrected using a three-point baseline at 1800, 1200, and 800 cm−1. Residual MMA
absorbance peaks were then subtracted using the relevant MMA reference
spectrum for each sample by iterative manual subtraction. A residual 1730 cm−1
MMA band remained after MMA subtraction, which was not used for analysis.
Spectroscopic parameters calculated were integrated peaks areas of the
following bands: phosphate (1180–916 cm−1), amide I (1588–1712 cm−1) and II
(1600–1500 cm−1), and carbonate (890–852 cm−1). Ratios were calculated as
follows: mineral:matrix ratio (1180–916 cm−1/588–1712 cm−1), carbonate:
phosphate ratio (1180–916 cm−1/890–852 cm−1) ratio and amide I:II ratio
(1588–1712 cm−1/1600–1500 cm−1)70. Collagen crosslinking was determined by
spectral curve ﬁtting of the amide I and amide II peaks using Grams/AI (Version
9.2, Thermo Scientiﬁc, USA). The second derivative of each peak was used to
estimate subpeak positions at ~1660 and 1690 cm−1.
Polarized light FTIR imaging. To assess collagen compaction by a second method,
pFTIRI was applied to the same 3 μm tibial sections at the analysis region used for
sFTIRM. Larger regions were imaged using a 340 × 340 μm aperture on either side
of the 1500 μm mid-point. Tissue sections were scanned using a Hyperion
3000 spectral imaging system equipped with a Vertex-70 spectrometer (Bruker,
Germany), a liquid-N2-cooled focal plane array (FPA: 128 × 128 elements; 40 ×4
0μm each) detector and a Globar source. The FPA detector was continuously
maintained at liquid-N2 temperature by an automated reﬁlling system (Norhof
LN2 cooling system #606; Maarssen, The Netherlands). The microscope and
spectrometer were also continuously N2 purged and an insulation box protected
the sample stage from ambient air. For all FTIR image acquisitions, a ×15 mag-
niﬁcation level and condenser were used. High-resolution FTIR images were
obtained for microscopic analysis of tissue sections; 200 scans and an 8 cm−1
spectral resolution were used for image acquisition (140 ms FPA detector exposure
per scan; spectral range= 3800–900 cm−1). All FTIR images had an individual
pixel dimension of 2.6 × 2.6 μm, thus at ~λ/2 for the mid-IR spectral interval. All IR
images were obtained in transmission mode. The images were obtained from sub-
routines of the Opus 7.5 software (Bruker-Optics, France). To quantify region-
speciﬁc changes in amide I:II, the diaphyseal cortex was divided into three equal
parts: periosteal, central, and endosteal ROIs. Average spectra were extracted from
each region, baselined and MMA-subtracted, as above, but using CytoSpec
1.4.0.3 (Bruker). Integrations for the amide I and II peaks were: amide I
(1590–1730 cm−1) and amide II (921–1190 cm−1). Since collagen is by far the
major protein component of bone, we interpreted the amide I:II ratio as peptide
bond vibrations of the collagen molecule. The amide I (C=O stretch) and amide II
(C-N, N-H bend) molecular vibrations exhibit dichroism perpendicular and par-
allel to the collagen molecular triple helix axis, respectively15,31. The FTIR
microscope was coupled with two polarizing ﬁlters to measure molecular
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orientation of collagen ﬁbers relative to the plane of the tissue section. The 0°
polarizing ﬁlter was used to measure bonds in plane (parallel to the section). The
90° polarizing ﬁlter was used to measure bonds out of plane (perpendicular to the
section). This allowed quantiﬁcation of collagen ﬁbers aligned in different direc-
tions through the diaphyseal cortex.
RNA-sequencing. RNA samples were collected from ﬂushed femora of 12-week-
old female Dmp1Cre.Efnb2f/f and cousin-bred control mice. Samples were collected
on two occasions: on day 1, two Dmp1Cre.Efnb2f/f and three control samples were
collected, while on day 2, one sample of each genotype was collected. Bones were
snap frozen in liquid nitrogen, and then homogenized in QIAzol lysis reagent with
a Polytron PTA 20S homogenizer at 4 °C prior to RNA extraction with a RNeasy
Lipid Minikit (Qiagen). RNA-sequencing was conducted on an Illumina HiSeq at
the Australian Genome Research Facility to produce 100 bp paired-end reads.
Reads were mapped to the mouse genome (mm10) using Rsubread71. Read counts
were obtained using featureCounts and Rsubread’s inbuilt mm10 annotation72.
Gene annotation was obtained from the NCBI gene information ﬁle (downloaded 4
October 2016). Statistical analysis used the limma software package73. Genes were
retained in the analysis if they achieved at least 0.65 read counts per million (cpm)
in at least three samples. Immunoglobulin gene segments, ribosomal genes, pre-
dicted and pseudo genes, sex-linked genes (Y chromosome and Xist), and obsolete
Entrez Gene IDs were ﬁltered out. Quantile normalization was applied and read
counts were transformed to log 2 cpm. Linear models were used to test for
expression differences between deﬁcient vs. control samples. The day of sample
collection was included in the linear model as a blocking factor. Empirical sample
quality weights were estimated74. Differential expression between the genotypes
was assessed using empirical Bayes moderated t statistics allowing for an abun-
dance trend in the standard errors and for robust estimation of the Bayesian
hyperparameters75. The Benjamini and Hochberg method was used to adjust the p
values so as to control the false discovery rate.
Knockdown of EphrinB2 in Ocy454 cells. Two shRNA constructs were used to
knock down EphrinB2: shRNA 1 (5′-CGG-GTG-TTA-CAG-TAG-CCT-TAT-3′)
and shRNA 2 (5′-CAG-ATT-GTG-TAC-ATA-GAG-CAA-T-3′), both obtained
from Sigma-Aldrich (St. Louis, MO, USA). shRNA were cloned into the PLKO
lentiviral vector6 and infected by retrovirus into undifferentiated Ocy454 cells.
Infected cells were selected with puromycin (5 µg/mL) and cultured at permissive
temperature (33 °C) before transfer to 37 °C for differentiation. Knockdown was
validated by qRT-PCR using multiplex primers, as above.
Analysis of autophagy and mineralization in Ocy454 cells. To assess LC3
puncta formation, undifferentiated Ocy454 (vector and EphrinB2-deﬁcient)
cells were grown on 22 × 22 mm2 glass coverslips in a 24-well plate as above with
Dulbecco’s modiﬁed Eagle’s medium (DMEM). When cells reached 70% con-
ﬂuency, they were treated for 2 h with baﬁlomycin A1 (50 nM, Enzo, BML-
CM110), or remained in media. Following this cells were washed twice in PBS,
ﬁxed with 3.7% paraformaldehyde, and then quenched with DMEM/HEPES (pH
7.0). They were washed in PBS and then permeabilized with 0.2% NP-40 for
30 min. Later the cells were washed with PBS/1% bovine serum albumin (BSA)
twice and then left in the same solution at room temperature on a shaker for
15 min. Theys were incubated in LC3 primary antibody (MBL, M152-3) diluted
1:500 in PBS/BSA for 1 h at 37 °C. They were then washed 3 × 10min in PBS/BSA
on a shaker, followed by incubation of secondary antibody (Invitrogen Alexa-
Fluor 488 goat anti-mouse A21121) diluted in PBS/BSA (1:500) for 30 min at room
temperature in the dark. Cells were then washed 3 × 10 min in PBS/BSA before
mounting on glass slides using ProLongTM Gold antifade reagent with DAPI
(Invitrogen P36935). In Ocy454 Efnb2 knockdown cells, imaging was peformed at
×60 magniﬁcation and LC3 puncta were manually counted in ﬁve images, con-
taining approximately 15 cells per group; the average per image is reported.
To assess effects of EphrinB2-Fc, EphrinB2-Fc was clustered with
immunoglobulin G (IgG) prior to administration for 1 h10 in the presence or
absence of baﬁlomycin A1, or H1152 (Sigma). We developed an automated method
to quantify punctae. Z-stack images were obtained through the full height of the
cell layer. Green channel images were Z-projected to gain an overlap of all Z-stack
layers, so that all punctae appearing throughout the cell were counted. Channels
were split using ImageJ (version 1.48v, National Institutes of Health) and a lower
intensity threshold of 40 was used to eliminate non-speciﬁc background binding.
Cells were manually delineated and punctae with integrated intensity 15–255 were
automatically detected and counted in each cell using IMA on MetaMorph (version
7.8.6.0, Molecular Devices); four images were analyzed for each condition in each
experiment.
To test the level of autophagy in osteocytes lacking Efnb2, Ocy454 cells with
Efnb2 shRNA knockdown and vector controls were differentiated for 11 days and
treated with chloroquine (40 µm), a lysosomal degradation inhibitor, for 4 h.
Treated and untreated cells were then washed with PBS and lysed in 50 mM Tris,
pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM EGTA, 0.1% NaPyroP,
1% Triton X-100, Roche protease inhibitor. Samples were electrophoresed by 6%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to
Immobilon FL polyvinylidine-ﬂouride membrane (Millipore). Membranes were
blotted with antibodies raised against LC3B (D11, Cell Signaling Technology,
3868), followed by incubation with anti-rabbit IgG secondary antibody
ﬂuorescently labelled with IR680 (LI-COR Biosciences). Immunoblots were
visualized on an Odyssey membrane imaging system (LI-COR Biosciences) and the
LC3-II:I ratio was quantitated as the fold change of EphrinB2quine-treated samples
relative to untreated samples.
To assess mineralization, Ocy454 cells with and without Efnb2 knockdown were
cultured in the same media as above, plus β-glycerophosphate for 14 days (data
shown are with 10 mM, similar results were observed at 2 and 5 mM), stained with
Alizarin Red, solubilized, and measured against a standard curve76.
Transmission Electron Microscopy. Femora from female 12-week-old Dmp1Cre
and Dmp1Cre.Efnb2f/f mice were ﬁxed for a minimum of 24 h in Karnovsky’s
ﬁxative. Samples were post-ﬁxed in 1% osmium tetroxide/1.5% potassium ferro-
cyanide for 5 h and embedded in Spurr’s resin. Ultra-thin sections were stained
with uranyl acetate/Reynold’s lead citrate and examined with a Philips 300
transmission electron microscope at 60 kV11. Osteocyte images were obtained from
cells deeply embedded within the bone matrix.
Statistics. All graphs show mean ± SEM, SD, or 95% conﬁdence intervals, as indi-
cated in ﬁgure legends; number of samples (n) is reported in the ﬁgure legends.
Statistical signiﬁcance was determined by unpaired Student’s t tests for histomor-
phometric, mechanical, microCT, and cell culture analyses, and two-way analysis of
variance with Fisher’s least signiﬁcant difference test for sFTIRM-derived data
(GraphPad Prism 6 (version 6.05)). p < 0.05 was considered statistically signiﬁcant.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
RNA-sequencing data generated for this study is deposited with GEO, accession number
GSE110795. All other data are available from the corresponding author on request.
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